GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

GOSS · Jun 30, 2026

Gossamer Bio, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]

Inspectable configuration

State dimensions

Filing0001728117-26-000072General Corporate

Capex intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.capex_revenue_ratio

0.00% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generation0thOwn-history percentile · N=8

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-426.76% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient

Evidence method

Yoy · gp.fundamentals.revenue

-19.59% · CORE · NOT_ENOUGH_HISTORY

Operating margin63thOwn-history percentile · N=8

Evidence method

Level · gp.fundamentals.operating_margin

-282.25% · CORE · VALID

SBC intensity75thOwn-history percentile · N=8

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

26.66% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History5 statesHistory building

Jun 30, 20250/5 normalizedLevel 3 Sep 30, 20250/5 normalizedLevel 3 Dec 31, 20250/5 normalizedLevel 3 Mar 31, 20260/5 normalizedLevel 3 Jun 30, 20263/5 normalizedLevel 3

Period transition

What moved in the state?

Cash Generation Decreased

Previous: -228.38%
Current: -426.76%
Delta: -198.38%

Growth Decreased

Previous: 71.45%
Current: -19.59%
Delta: -91.05%

Profitability Decreased

Previous: -264.62%
Current: -282.25%
Delta: -17.63%

Sbc Intensity Decreased

Previous: 37.18%
Current: 26.66%
Delta: -10.52%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.

Research Graph

Related governed research

Compared To · Pharmaceutical Preparations peers →Transitioned To · GOSS Fundamental State →Transitioned To · GOSS CASH_GENERATION_DECREASED →Transitioned To · GOSS GROWTH_DECREASED →Transitioned To · GOSS PROFITABILITY_DECREASED →Transitioned To · GOSS SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.